Notion of threshold in mutagenesis: Implications for mutagenic and carcinogenic risk assessment;La notion de seuil en mutagenèse: Implications pour l'évaluation du risque mutagène et cancérogène

Annales Pharmaceutiques Francaises

Volumn 65, Issue 6, 2007, Pages 404-414

  Marzin, D ^a,b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIV LILLE   (France)

Author keywords

Carcinogenesis; Mutagenesis; Risk Assessment; Threshold

Indexed keywords

ANEUGEN; ANTHRACYCLINE; CARCINOGEN; CLASTOGEN; DAUNORUBICIN; DIETHYLSTILBESTROL; DNA; DNA POLYMERASE; DNA TOPOISOMERASE INHIBITOR; MUTAGENIC AGENT; RIBONUCLEOTIDE REDUCTASE; VINBLASTINE;

ANEUPLOIDY; APOPTOSIS; BONE MARROW; CANCER RISK; CARCINOGENICITY; CHROMOSOME; CONFERENCE PAPER; DNA ADDUCT; DNA DAMAGE; DNA REPAIR; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; GENOTOXICITY; HUMAN; HYPERTHERMIA; HYPOTHERMIA; MICRONUCLEUS; MUTAGENESIS; NONHUMAN; RISK ASSESSMENT;

EID: 37149034635     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4509(07)74200-1     Document Type: Conference Paper

References (36)

1. Kirsch-Volders M, Vanhauwaert A, Eichenlaub-Ritter U, Decordier I. Indirect mechanisms of genotoxicity. Toxicol Lett 2003; 140-141: 63-74.
2. Jenkins GJ, Doak SH, Johnson GE, Quick E, Waters EM, Parry JM. Do dose response thresholds exist for genotoxic alkylating agents? Mutagenesis 2005; 20: 389-98.
3. Seiler, JP Apparent and real threshold: a study on two mutagens in: Scott, D., Bridges, B.A., Sobbels, F.H. (Eds) Progress in Genetic Toxicology. Elsevier/North-Holland Biomedical Press: 1977, 233-8.
4. Kirsch-Volders M, Aardema M, Elhajouji A. Concepts of threshold in mutagenesis and carcinogenesis. Mutat Res 2000; 464: 3-11.
5. Elhajouji A, Van Hummelen P, Kirsch-Volders M. Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes. Environ Mol Mutagen 1995; 26: 292-304.
6. Elhajouji A, Cunha M, Kirsch-Volders M. Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononucleates in the cytokinesis-block assay. Mutagenesis 1998; 13: 193-8.
7. Speit G, Autrup H, Crebelli R, Henderson L, Kirsch-Volders M, Madle S, Parry JM, Sarrif AM, Vrijhof H. Thresholds in genetic toxicology - concluding remarks. Mutat Res 2000; 464: 149-53.
8. Elhajouji A, Tibaldi F, Kirsch-Volders M. Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis 1997; 12: 133-40.
9. Ferguson LR, Baguley BC. Topoisomerase II enzymes and mutagenicity. Environ Mol Mutagen 1994; 24: 245-61.
10. Anderson RD, Berger NA. International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents. Mutat Res 1994; 309: 109-42.
11. Albertini S, Chetelat AA, Miller B, Muster W, Pujadas E, Strobel R, Gocke E. Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems. Mutagenesis 1995; 10: 343-51.
12. Galloway SM, Miller JE, Armstrong MJ, Bean CL, Skopek TR, Nichols WW. DNA synthesis inhibition as an indirect mechanism of chromosome aberrations: comparison of DNA-reactive and non-DNA-reactive clastogens. Mutat Res 1998; 400: 169-86.
13. Goncalves O, Drobetsky E, Meuth M. Structural alterations of the aprt locus induced by deoxyribonucleoside triphosphate pool imbalances in Chinese hamster ovary cells. Mol Cell Biol 1984; 4: 1792-9.
14. Meuth M. The genetic consequences of nucleotide precursor pool imbalance in mammalian cells. Mutat Res 1984; 126: 107-12.
15. Phear G, Meuth M. The genetic consequences of DNA precursor pool imbalance: sequence analysis of mutations induced by excess thymidine at the hamster aprt locus. Mutat Res 1989; 214: 201-6.
16. Kunz BA, Kohalmi SE, Kunkel TA, Mathews CK, McIntosh EM, Reidy JA. International Commission for Protection Against Environmental Mutagens and Carcinogens. Deoxyribonucleoside triphosphate levels: a critical factor in the maintenance of genetic stability. Mutat Res 1994; 318: 1-64.
17. Haynes P, Lambert TR, Mitchell ID. Comparative in-vivo genotoxicity of antiviral nucleoside analogues; penciclovir, acyclovir, ganciclovir and the xanthine analogue, caffeine, in the mouse bone marrow micronucleus assay. Mutat Res 1996; 369: 65-74.
18. Sirover MA, Loeb LA. Metal-induced infidelity during DNA synthesis. Proc Natl Acad Sci USA 1976; 73: 2331-5.
19. Sirover MA, Loeb LA. On the fidelity of DNA synthesis: effects of steroids and intercalating agents. Chem Biol Interact 1980; 30: 1-8.
20. Singh J, Snow ET. Chromium(III) decreases the fidelity of human DNA polymerase beta. Biochemistry 1998; 37: 9371-8.
21. Favor J, Sund M, Neuhauser-Klaus A, Ehling UH. A dose-response analysis of ethylnitrosourea-induced recessive specific-locus mutations in treated spermatogonia of the mouse. Mutat Res 1990; 231: 47-54.
22. Favor J, Neuhauser-Klaus A, Ehling UH, Wulff A, van Zeeland AA. The effect of the interval between dose applications on the observed specific-locus mutation rate in the mouse following fractionated treatments of spermatogonia with ethylnitrosourea. Mutat Res 1997; 374: 193-9.
23. Bergman K, Muller L, Teigen SW. Series: current issues in mutagenesis and carcinogenesis, No. 65. The genotoxicity and carcinogenicity of paracetamol: a regulatory (re)view. Mutat Res 1996; 349: 263-88.
24. Henderson L, Albertini S, Aardema M. Thresholds in genotoxicity responses. Mutat Res 2000; 46: 123-8.
25. Yajima N, Kurata Y, Sawai T, Takeshita Y. Comparative studies in induction of micronuclei by three genetically recombinant and urinary human erythropoietins. Mutagenesis 1993; 8: 237-41.
26. Steinheider G, Neth R, Marquardt H. Évaluation of nongenotoxic and genotoxic factors modulating the frequency of micronucleated erythrocytes in the peripheral blood of mice. Cell Biol Toxicol 1986; 2: 197-211.
27. Asanami S, Shimono K. Hypothermia induces micronuclei in mouse bone marrow cells. Mutat Res 1997; 393: 91-8.
28. Asanami S, Shimono K. Effects of chemically- and environmentally-induced hypothermia on micronucleus induction in rats. Mutat Res 2000; 471: 81-6.
29. Asanami S, Shimono K. The effect of hyperthermia on micronucleus induction by mutagens in mice. Mutat Res 1999; 446: 149-54.
30. Meintieres S, Biola A, Pallardy M, Marzin D. Apoptosis can be a confusing factor in vitro clastogenic assays. Mutagenesis 2001; 16: 243-50.
31. Meintieres S, Biola A, Pallardy M, Marzin D. Using CTLL-2 and CTLL-2 bcl2 cells to avoid interference by apoptosis in the in vitro micronucleus test. Environ Mol Mutagen 2003; 41: 14-27.
32. Carmichael PL, Mills JJ, Campbell M, Basu M, Caldwell J. Mechanisms of hormonal carcinogenesis in the p53+/-hemizygous knockout mouse: studies with diethylstilbestrol. Toxicol Pathol 2001; 29 (Suppl.): 155-60
33. Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 1999; 57: 727-41.
34. Grawe J, Adler ID, Nusse M. Quantitative and qualitative studies of micronucleus induction in mouse erythrocytes using flow cytometry. II. Analysis of micronuclei of aneugenic and clastogenic origin by dual-colour FISH on populations of bone marrow PCEs flow sorted on the basis of their relative DNA content. Mutagenesis 1997; 12: 9-16.
35. Vanhauwaert A, Vanparys P, Kirsch-Volders M. The in vivo gut micronucleus test detects clastogens and aneugens given by gavage. Mutagenesis 2001; 16: 39-50.
36. Steiblen G Orsiere T Pallen C Botta A Marzin D. Comparison of the relative sensitivity of human lymphocytes and mouse splenocytes to two spindle poisons. Mutat Res 2005; 588: 143-51.